News on GlaxoSmithKline (Ticker: GSK) continually updated from thousands of sources around the net.
18 hrs ago | Seeking Alpha
It has become increasingly difficult to find strong businesses trading at low P/E ratios in today's overvalued market.
Trending on the Topix Network
Drugs giant GlaxoSmithKline publishes second quarter results on Wednesday as a tangled web of allegations linked to a bribery probe by Chinese authorities continues to hang over the UK-based company.
BSkyB is putting the final touches to a plan to buy its sister companies in Italy and Germany and will announce the takeovers in the next two weeks, the Sunday Times reported.
The cost consequences of the Lincoln Novartis plant's two and a half years of quality-control troubles appear to be fading away as it restores more production and approaches new ownership and a new name, GSK Consumer Healthcare.
Chinese authorities said they plan to hold an open trial when they try two foreign investigators tied to U.K. drug giant GlaxoSmithKline PLC on charges of illegally purchasing personal information on Chinese nationals.
Economy The IMF praised the formation of the New Development Bank and reserves fund launched by BRICS countries yesterday, and announced that it would like to work together with the monumental project.
Mylan Inc. today announced that the U.S. District Court for the District of New Jersey granted its motion for a permanent injunction against GlaxoSmithKline in relation to Paroxetine CR, the generic version of GSK's PaxilA CR.
Profits during the April-June quarter rose to $3.28 billion, up from $3.18 billion in the same quarter of 2013, helped by "strong innovation momentum" and rising sales in some of its household brands, the Basel-based company reported.
The Paxil birth-defect litigation in Philadelphia, which once included about 1,000 cases, now has only two left in the city's court system.
The UK advertising watchdog has dropped a barbell on drug giant GlaxoSmithKline's MaxiNutrition sports nutrition brand over "exaggerated" use of EU-approved protein-recovery claims.
ISIS-TTRRx is an antisense drug in development with GSK for the treatment of transthyretin amyloidosis, a severe and rare genetic disease characterized by progressive dysfunction of peripheral nerve and/or heart tissues.
Expected 28 - 33 million doses of four-strain and three-strain flu shots will help meet U.S. public health needs GSK [LSE/NYSE: GSK] announced today it has begun shipping FLUARIXA QUADRIVALENT doses to U.S. healthcare providers.
Three former Chinese employees of GlaxoSmithKline PLC, which is embroiled in a long-running corruption probe in China, are seeking compensation for illegal dismissal from their jobs, a lawyer representing them told Reuters.
Updated: Mon Jul 21, 2014 08:04 am
Copyright © 2014 Topix LLC